what’s so special about next generation sequencing

8
3/11/2015 What’s so special about Next Generation sequencing? » Oxbridge Biotech Roundtable http://www.oxbridgebiotech.com/review/researchandpolicy/whatssospecialaboutnextgenerationsequencing/ 1/8 Menu Home About Team Scientific Advisory Board Events Consulting About Prior Projects OneStart Roundtable Review In Touch Core Concepts Policy Pulse Business Bytes News of the Week Hightable OneStart Roche EIN Jobs Join OBR Join OBR > Join OBR for free to stay uptodate with all OBR initiatives: events, consulting opportunities, partner initiatives, biotech opportunities, and more. You need to be a registered member in order to be able to sign up to our events. Oxbridge Biotech Roundtable > Roundtable Review > Policy Pulse > What’s so special about Next Generation sequencing? What’s so special about Next Generation sequencing? Sunday, 19th August 2012 Policy Pulse Next Generation DNA sequencing technology is progressing rapidly, producing considerable advancements in diverse fields ranging from retracing the steps of a 5,000year old Iceman to developing breast cancer therapies. A search for Next Generation Sequencing in the PubMed database reveals over 1,000 papers published in the last year alone, with many genetics studies reaching mainstream news sites such as the BBC, Guardian Science and the Telegraph. With these new technologies a wide range of science is now feasible that was previously unimaginable. Wholegenome sequencing of the 5,000year old Iceman Ӧtzi, found in the French Alps in 1991, revealed a genetic predisposition to heart disease and valuable historical information about Ӧtzi’s origin, blood type and clues to his appearance (1,2). The Human Microbiome Project aims to sequence all the bacteria and microbes in the human body (3) improving diagnosis, treatment and understanding of an array of diseases. Sequencing of cancer genomes is revealing a wide genetic variation within a single tumour, with implications for drug resistance and treatment of the disease (46). The Cancer Genomics Hub was announced in California in May this year – a collection of all the data from the three big sequencing centres in the USA, holding 5 petabytes of information on cancer genomics (7,8). While these and other projects advance rapidly, they are dependent on the technology and how governments, doctors and scientists are choosing to use it. Earlier this year, the announcement by Oxford Nanopore Technologies (9) of a USBsized machine in which sequencing can be carried out in as little as 15 minutes with an expected retail of around $900 will have important implications in both academic and medical labs. Paving the way, Norway announced this

Upload: damjan-af

Post on 04-Oct-2015

7 views

Category:

Documents


6 download

DESCRIPTION

NGS

TRANSCRIPT

  • 3/11/2015 WhatssospecialaboutNextGenerationsequencing?OxbridgeBiotechRoundtable

    http://www.oxbridgebiotech.com/review/researchandpolicy/whatssospecialaboutnextgenerationsequencing/ 1/8

    Menu

    HomeAbout

    TeamScientificAdvisoryBoard

    EventsConsulting

    AboutPriorProjects

    OneStartRoundtableReview

    InTouchCoreConceptsPolicyPulseBusinessBytesNewsoftheWeekHightableOneStart

    RocheEINJobs

    JoinOBR

    JoinOBR>JoinOBRforfreetostayuptodatewithallOBRinitiatives:events,consultingopportunities,partnerinitiatives,biotechopportunities,andmore.Youneedtobearegisteredmemberinordertobeabletosignuptoourevents.OxbridgeBiotechRoundtable>RoundtableReview>PolicyPulse>WhatssospecialaboutNextGenerationsequencing?

    WhatssospecialaboutNextGenerationsequencing?

    Sunday,19thAugust2012PolicyPulse

    NextGenerationDNAsequencingtechnologyisprogressingrapidly,producingconsiderableadvancementsindiversefieldsrangingfromretracingthestepsofa5,000yearoldIcemantodevelopingbreastcancertherapies.AsearchforNextGenerationSequencinginthePubMeddatabaserevealsover1,000paperspublishedinthelastyearalone,withmanygeneticsstudiesreachingmainstreamnewssitessuchastheBBC,GuardianScienceandtheTelegraph.Withthesenewtechnologiesawiderangeofscienceisnowfeasiblethatwaspreviouslyunimaginable.Wholegenomesequencingofthe5,000yearoldIcemantzi,foundintheFrenchAlpsin1991,revealedageneticpredispositiontoheartdiseaseandvaluablehistoricalinformationabouttzisorigin,bloodtypeandcluestohisappearance(1,2).TheHumanMicrobiomeProjectaimstosequenceallthebacteriaandmicrobesinthehumanbody(3)improvingdiagnosis,treatmentandunderstandingofanarrayofdiseases.Sequencingofcancergenomesisrevealingawidegeneticvariationwithinasingletumour,withimplicationsfordrugresistanceandtreatmentofthedisease(46).TheCancerGenomicsHubwasannouncedinCaliforniainMaythisyearacollectionofallthedatafromthethreebigsequencingcentresintheUSA,holding5petabytesofinformationoncancergenomics(7,8).

    Whiletheseandotherprojectsadvancerapidly,theyaredependentonthetechnologyandhowgovernments,doctorsandscientistsarechoosingtouseit.Earlierthisyear,theannouncementbyOxfordNanoporeTechnologies(9)ofaUSBsizedmachineinwhichsequencingcanbecarriedoutinaslittleas15minuteswithanexpectedretailofaround$900willhaveimportantimplicationsinbothacademicandmedicallabs.Pavingtheway,Norwayannouncedthis

    http://www.oxbridgebiotech.com/about-obr/advisory-board/http://www.oxbridgebiotech.com/review/category/research-and-policy/http://www.oxbridgebiotech.com/review/http://www.oxbridgebiotech.com/about-obr/http://onestart.co/http://www.oxbridgebiotech.com/obrconsulting/projects/http://www.oxbridgebiotech.com/jobs/http://www.oxbridgebiotech.com/about-obr/team/http://www.oxbridgebiotech.com/roche/ein/http://www.oxbridgebiotech.com/review/category/careers-2/http://www.oxbridgebiotech.com/joinhttp://www.oxbridgebiotech.com/review/category/business-development/http://www.oxbridgebiotech.com/review/category/news-2/http://www.oxbridgebiotech.com/review/category/science-basics/http://www.oxbridgebiotech.com/http://www.oxbridgebiotech.com/review/category/research-and-policy/http://www.oxbridgebiotech.com/review/http://www.oxbridgebiotech.com/joinhttp://www.oxbridgebiotech.com/obrconsulting/http://www.oxbridgebiotech.com/obrconsulting/http://www.eventbrite.com/o/oxbridge-biotech-roundtable-and-sr-one-7399020109http://www.oxbridgebiotech.com/http://www.oxbridgebiotech.com/review/category/obr-news/http://www.oxbridgebiotech.com/review/category/research-and-policy/http://www.oxbridgebiotech.com/review/category/onestart/

  • 3/11/2015 WhatssospecialaboutNextGenerationsequencing?OxbridgeBiotechRoundtable

    http://www.oxbridgebiotech.com/review/researchandpolicy/whatssospecialaboutnextgenerationsequencing/ 2/8

    yearthatNextGenerationSequencingwillbeincludedinitshealthserviceforthetreatmentofcancer(10),whilemanyothercountriesareusingNextGenerationTechnologiesinresearchhospitals.Whiletheseadvancementssoundspectacular,theyhavecomeafterthehardworkofgreatscientistsofanearlierera,andmuchworkremainstoovercomethelingeringhurdlesofthescienceandalsotheregulationofNextGenerationsequencing.

    Lettherebelight

    WhileNextGenerationSequencingtechnologiesallowforthesequencingofawholegenomeinjustafewdays,originalsequencingtechnologiesofteninvolveddangerousradiationandtedioustimeconsumingsteps.

    Thefirstbigbreakthroughsinsequencingtechnologieshappenedinthemid1970s,withaseriesofmethodsbasedonpolyacrylamidegelelectrophoresis,whichallowsDNAfragmentstobedistinguishedbytheirsize.FrederickSangersinitialplusandminussequencingmethod,publishedin1975,wasthefirstofthese.Itwasdependentoncomparingthelengthsofnucleotidesextendedinthepresence(plus)orabsence(minus)ofaparticularnucleicacid(A,C,T,orG).Whilethiswasquiteanadvance,thismethodhadlimitations:itcouldonlydetermine50basesperreaction,notallbasesinthemiddleoftheruncouldbedetermined,anditwasdifficulttodeterminethelengthofthesequencingruns(11).

    Twomethodspublishedin1977tookthisconceptevenfurther.ThefirstofthesewasMaxamGilbertsequencing,orChemicalSequencing,developedbyAllanMaxamandWalterGilbert,andwasthefirstwidelyusedsequencingmethod.TheprocessusedradioactivelabelingofdoublestrandedDNAfragments.TheDNAwasthencleavedbybasespecificchemicalreactionsandthefragmentsseparatedbyelectrophoresis(Fig.1a).ThesecondmethodwasFrederickSangersimprovementonhisplusandminusmethodwiththedideoxyorchainterminationmethod.Theprocessisstillwidelyusedtoday.InsteadofchemicalcleavageoftheDNA,theprocessdependson32Plabelledchainterminatingdideoxynucleotides,whichpreventfurtherextensionofthesequenceuponincorporation[Fig.1b].Eachreactionthusgeneratesfragmentsofincreasingsize,endingatthebasespecifiedbythereactioni.e.eachA,T,CorG.Thismethodoriginallyallowedreadingofsequencesupto100basepairslong(11).SangerandGilbertreceivedtheNobelPrizeforchemistryin1980fortheircontributiontoDNAsequencingtechnologies,sharedwithPaulBergforhisworkonthechemistryofDNAandrecombinantDNA(12).Improvementsinthegeltechnologyandbettergelresolution,duetoradioactivelabellingwith35Sorfluorescenttagsratherthan32P,allowedsequencingofupto30,000basesofDNAinoneday,withuptoapproximately400basessequencedperreactionbytheearly1980s(11).

    Figure1TheOriginalSequencingTechnologiesA)MaxamGilbert(Chemicalsequencing)andB)SangerDideoxyChainterminationsequencing.Part3showsDNAfragmentsresolvedonapolyacrylamidegelandasequencingtracefromamodernautomatedsequencingmachine.FiguresbySarahEtheridge

    http://obrreview.com/wp-content/uploads/2012/08/Figure-1-cropped.jpg

  • 3/11/2015 WhatssospecialaboutNextGenerationsequencing?OxbridgeBiotechRoundtable

    http://www.oxbridgebiotech.com/review/researchandpolicy/whatssospecialaboutnextgenerationsequencing/ 3/8

    Withproductionofsuchlargequantitiesofsequencingdata,thedataprocessingsoonbecamearesearchtopicinitselfandthebirthofbioinformaticswasinevitable.Thenin1986,encouragingtheriseofthisnewfield,LeroyHoodatCaltech,incollaborationwithAppliedBiosystems(ABI),publishedthefirstreportofsequencingdatabeingcollecteddirectlytoacomputer.Thetechnology,basedonSangersdideoxymethod,usessequencingprimersfluorescentlyendlabelledwithfourdifferentcolourstorepresenteachbase.Reactionsarethenrunsimultaneouslythroughapolyacrylamidetubegel,withtheDNArecognisedbyitsfluorescenceasitpassesadetector.AseriesofnewandimprovedABImachineswerereleasedinthefollowingyearswithdedicatedsequencingfacilitiessetupwiththeeventualaimofsequencingthehumangenome(11).

    Sequencingjustgotbetter

    DiscussionsabouttheHumanGenomeProjectofficiallybeganatameetingin1985,witha5yearplanpublishedtotheDOEandNIHin1990.AlthoughbeginningintheUS,theprojectbecameaninternationalcollaborationbetweencentresintheUS,EuropeandJapanwitheachcentrefocusingonparticularregionsofthegenome.In1992,CraigVenterandcolleaguesattheNIHsetuponeofthefirstdedicatedsequencingfacilitiesTheInstituteforGenomicResearchTIGR.

    Figure2WholeGenomeShotgunsequencing(WGS)Adaptedfrom:http://www.bio.davidson.edu/courses/genomics/method/shotgun.htmlandhttp://www.biomedcentral.com/14712164/11/438/figure/F1?highres=y

    In1995,hisgroupandcollaboratorsreportedthecompletegenomesequencesofthebacteriaHaemophilusinfluenzaeandMycoplasmagenitalium,thelargestgenomicsequencespublishedatthattime.VenterandhisteamintroducedcriticalimprovementstoamethodknownastheWholeGenomeShotgun(WGS)approach,whichlaterformedthebasisofNextGenerationSequencing.InWGS,wholegenomicDNAisrandomlyfragmentedandclonedintoE.Coli[Fig.2].Theclonesaresequencedatrandomandassembledwithspecialisedsoftware.TheTIGRassemblerwasoneofthefirstpiecesofsoftwarethatallowedtheanalysisofthousandsofsequencereadsmakinginterpretationofthedatapossible.

    ThedevelopmentoftheABI3700Capillarysequencerinthelate1990swasanotherkeyprogressionduringthistime,

    http://obrreview.com/wp-content/uploads/2012/08/WGS-Figure-2-cropped.jpg

  • 3/11/2015 WhatssospecialaboutNextGenerationsequencing?OxbridgeBiotechRoundtable

    http://www.oxbridgebiotech.com/review/researchandpolicy/whatssospecialaboutnextgenerationsequencing/ 4/8

    allowingsimultaneoussequencingofupto96samplesthroughseparatecapillariesfilledwithnoncrosslinkedpolymermatrix.CraigVenterandcolleaguesadoptedtheABI3700withtheircompanyCelera,whichworkedindirectcompetitiontothepublicHumanGenomeproject.Theresultsofeachprojectwerepublishedinthesameweek,withthefirstdraftsequencesoftheHumanGenomeProjectpublishedinNatureandSciencein2001.

    WhiletheWGSapproachledtothedevelopmentoftheNextGenerationSequencingmethods,whichreadhundredsorthousandsofsequencesinparallel,thehighthroughputtechnologycancompromisetheaccuracyandlengthofthesequencessuchthatfollowupwithdideoxySangersequencingisoftennecessary.ExomeSequencing,alsoknownasTargetedExomeCapture,isavariationofNextGenerationSequencingthatonlysequencesDNAregionsthatencodeproteins,knownasexons.Exonsonlyaccountforaround1%ofthegenome,sothismethodallowstheexclusionofthelargeintronicsequencesfoundwithinandbetweengenes,thussavingtimeandreducingcost.Thismethoddoesriskexcludingmutationsinnoncodingregionsofthegenome,however,andseveraldiseaseshaverecentlybeenlinkedtomutationsintheseareas.

    SomeofthefirstcommerciallyavailableNextGenerationtechnologiesweredevelopedby454LifeSciencesandSolexatechnology,laterpurchasedbyIllumina.BothmethodsinvolverandomshearingofgenomicDNA,followedbylinkingtobeadsoraspecialisedslide.The454LifeSciencessystem[Fig.3A]isbasedonthepyrosequencingmethod,whichallowsshotgunsequencingwithoutcloninganyoftheDNA.PyrosequencinginvolvesaDNAsynthesisreaction,witheachofthefourdNTPbasesappliedoneafteranother.DuringaDNAsynthesisreaction,aPhosphategroupisreleasedwhentwonucleotidesarebound.PyrosequencingmeasurestheamountofphosphatereleasedaseachdNTPisaddedtothereactionandincorporatedintothesequence(13).Drawbacksincludetheriskofbasesbeingfalselyinsertedorremoved/deletedfromthesequenceduetomisjudgmentsinthelengthofthesequencingrun.TheseerrorsareknownasIndels.Themethodcanproduceonemillionbasesofsequencewith99.5%accuracy,witheachreadmorethan250baseslong(13).Solexatechnology[Fig.3B]alsousesDNAsynthesisreactionsbutmeasuringfluorescenceratherthanpyrophosphatereselase.Fluorescentlylabeledchainterminatingnucleotidesareincorporatedintothesequenceandmeasuredbyadetector.However,theincorporationofthechainterminatingnucleotideisreversible,allowingthesynthesistocontinueuntilanotherchainterminatingnucleotideisincorporated,sothebasesineachsequencearemeasuredoneatatime.Aseachbaseofthesequenceisreadinanindividualstep,thenumberofindelsisreducedcomparedtothe454technology.Reversibledyeterminatornucleotidesarenotincorporatedefficiently,meaningasmallerreadlengthcomparedtothe454andmorebasesubstitutionerrors.Themethodcanproduce1billionbasesof3040basesequencesinasinglerun(14).

    Figure3NextGenerationSequencingMethodsA)454Methodadaptedfrom(13)http://www.wellcome.ac.uk/Educationresources/Teachingandeducation/Animations/DNA/WTX056046.htm

    http://obrreview.com/wp-content/uploads/2012/08/Next-Gen-Figure-3-a-and-b-cropped.jpg

  • 3/11/2015 WhatssospecialaboutNextGenerationsequencing?OxbridgeBiotechRoundtable

    http://www.oxbridgebiotech.com/review/researchandpolicy/whatssospecialaboutnextgenerationsequencing/ 5/8

    B)SolexaTechnology,adaptedfrom(14)http://wellcome.ac.uk/Educationresources/Teachingandeducation/Animations/DNA/WTX056051.htm

    Asdescribedabove,theannouncementofthereleaseoftheNanoporeSequencingtechnologyisanexcitingdevelopment,withthepotentialtorevolutionisethesequencingworldandgenomicmedicine.Thetechnologyisremarkablysmart:DNAnucleotidesareguidedthroughnanoporesbyanenzyme,interruptingtheflowofionsthroughtheporewhentheypassthrough.Eachnucleotidecanthusbedetectedasadistinctelectricalsignalduetodifferencesintheinterruptionofionflow.LongstrandsofDNAcanbereadnucleotidebynucleotideinthismanner[Fig.4].Furtherdetailsofthetechnologyanditscompetitioncanbefoundhere.NanoporetechnologyrepresentsarapidstepforwardbecausenomodificationoramplificationoftheDNAisneededbeforesequencingtakesplace,savingtimeandreducingerrorssosequencingcanbecarriedoutinaslittleas15minutes.TheportableMinIONdevicewouldallowdoctorstosequencedirectlyfromapatientsbloodintheclinic,whilethelargerGridIONdevicecansequenceanentiregenomeinaday.Thelowoperatingandretailcostsalsomeanthatthegoalofthelongawaited$1,000dollargenomehasnowbeenreached,makinggenomicmedicinearealistictreatmentoptionformanypatientsinthenearfuture(1517).

    Figure4NanoporeSequencingTechnologyProteinnanoporesaresetinanelectricallyresistantmembranebilayer.Anioniccurrentispassedthroughthenanopores,andifananalytepassesthroughtheporeornearitsaperture,acharacteristicdisruptionofcurrentiscreated.Bymeasuringthatcurrent,itispossibletoidentifythemoleculeinquestion.Duringsequencing,forexample,aDNAstrandisfedthroughthenanoporebyanenzymeandeachofthefourstandardDNAbasesG,A,TandCcanbeidentified.From(16)http://www.nanoporetech.com/technology/introductiontonanoporesensing/introductiontonanoporesensing

    Anethicalnomansland

    Withtherapidlydecreasingcostandtimeofgenomesequencingcomeseverallegalandethicalissues.Ownershipofthesequencingdata,storage,accessandprivacyaresignificantconcernsoncethepatientssamplehasbeentaken.Afearofgeneticdiscrimination,forexamplebyinsurancecompanies,mayalsopreventpeopleundergoinggenetictestingwhenitwouldbeofbenefit(1820).Ownershipofdonatedsamplesbecomesaparticularissuewhenthesamplesproducescientificbreakthroughsofusetothebiotechindustry.OnefamousexampleofcontroversialuseofapatienttissueisHeLacells,thefirstimmortalisedcellline,whichwereisolatedfromacervicalcancerbiopsytakenwithoutconsentfromthepatientHenriettaLacksinthe1950s(21).

    ArelatedcaseinvolvinggeneticinformationisthatofGreenbergv.MiamiChildrensResearchInstitute(2003).TheplaintiffsinthiscasewereagroupoffamiliesaffectedbyCanavandisease,aninheriteddegenerativebrainconditionresultingfromaninabilitytoprocesstheaminoacidAsparticacid.ThefamilieshadpreviouslypersuadedDrReubenMatalontoconductresearchtoidentifythegeneresponsibleforthediseaseandhadsetupatissuebankwiththeaimoffindinganaffordablediagnostictest.Theydidindeedfindthegeneanddevelopatest.However,Matalonwentontoobtainapatentforthegenewithoutthefamiliesconsent,sohisemployer,MiamiChildrensResearchInstitute,gainedcontroloftestingforthedisease.Thefamiliesbelievedthattheseactionsdisagreedwiththeoriginalpurposeofthedonations.Thecourtdidnotfindthatthefamilieshadapropertyrighttothetissue,however,statingthatthepropertyrightinbloodandtissuesamplesevaporatesoncethesampleisvoluntarilygiventoathirdparty(22,23)

    Thegeneralfeelingbythecourtsappearedtobethatthereisadangerifpeoplecanexploittheirbodiesforfinancialgain,andthatthismaynegativelyimpactonthebiotechindustryandthereforeonthedevelopmentofresearchand

    http://obrreview.com/wp-content/uploads/2012/08/Nanopore-cropped.jpghttp://obrreview.com/2012/oxford-nanopores-pocket-dna-sequencer

  • 3/11/2015 WhatssospecialaboutNextGenerationsequencing?OxbridgeBiotechRoundtable

    http://www.oxbridgebiotech.com/review/researchandpolicy/whatssospecialaboutnextgenerationsequencing/ 6/8

    healthcare.Somearguefortissuedonorstobenamedasinventorsonpatentsarisingfromtheirtissueasuniquematerial,whichmayincentivisetissuedonation(23).Theargumentagainstthisisthatapatentrequiresaninventivestepandthereforedetailedknowledgeofhowtoadvancetheresearchusingthedonatedsample..TheargumentislessthanclearwiththeGreenbergcase,asthefamilieswishedtheirtissuetobeusedforresearch.However,theymaynothavetheknowledgetoconducttheexperimentsneededtoidentifythegeneanddevelopthediagnosticprocedures.Aninnovativemother,SharonTerry,whosetwochildrenareaffectedbytheinheritedconditionpseudoxanthomaelasticum(PXE)wasnamedascoinventorforthepatentforthePXEgene(ABCC6)whichaffectsconnectivetissueintheskin,retinaandthecardiovascularsystem.ShefoundedPXEinternationalwithherhusband,settingupacentralizedtissuebankandcoordinatinggenetic,epidemiologicalandotherstudies.MrsTerryisalsonowCEOoftheGeneticAlliance(2325).

    Personalisedmedicineandthefuture

    Sequencingtechnologyhasadvancedmassivelysinceitsbirthinthe1970s,withmanytechnologiesreleasedthisyearpotentiallyallowingsequencingofwholegenomesinadayforlessthan$1,000,agoalthatcouldonlybedreamedaboutafewyearsago.

    Thetechnologicaldevelopmentsraiseimportantethicalissues,whichareslowlybeingaddressed.Rapidinterpretationofthemassesofdataproducedcurrentlyrequireshighlyspecializedsoftware,andrepresentsoneofthenextchallengestobringingwholegenomesequencingroutinelytotheclinic.Theareaofpharmacogenomicslookingatgeneticcombinationsorbarcodesofanindividualfortargetingtherapy,asopposedtohominginonaspecificgeneislikelytobeanimportantfocusfordeterminingpeopleatriskofcommondiseases.Identificationofthe10typesofbreastcancerearlierthisyearrepresentsanexampleofhowthisareaisprogressing(6).Thedevelopmentsmayalsotransformthewaythepharmaceuticalindustryworks.EliLilly,forexample,arenowdevelopingmanyoftheirnewtherapiesbasedonspecificbiomarkers(28).

    Thenextstepandacurrenthottopicistoprovidefurtherinsightintotheworkingsofthebodyinhealthanddiseasebylookingattheproteinsactiveinparticularcelltypes.ThiscanbeachievedinpartbylookingatthemessengerRNA(transcriptomics)andnoncodingRNAsshowinghowgeneticsaffectsthecellsystemincombinationwithenvironmentalinfluences.Withthespeedatwhichtechnologyisdevelopingperhapseventhesehurdleswillsoonbeovercometoincreasetheefficiencyandefficacyofsequencingandpersonalisedmedicineintheclinic.Thereisnodoubt,however,thattherapidprogresswehaveseensincethefirstsequencingtechnologiesisalreadyhighlyremarkable.

    References

    (1)http://www.sciencedaily.com/releases/2012/02/120228123847.htm

    (2)http://www.bbc.co.uk/news/scienceenvironment17191398

    (3)www.nature.com/news/microbiomesequencingoffershopefordiagnostics1.10299)

    (4)http://www.sanger.ac.uk/genetics/CGP/

    (5)http://www.sciencenews.org/view/generic/id/38320/title/First_complete_cancer_genome_sequenced

    (6)Curtisetal(2012),Thegenomicandtranscriptomicarchitectureof2,000breasttumoursrevealsnovelsubgroups,Nature,publishedonlineApril2012,doi:10.1038/nature10983

    (7)http://news.sciencemag.org/scienceinsider/2012/05/worldslargesthubforcancer.html?ref=hp

    (8)http://blogs.nature.com/news/2012/05/uscancergenomerepositoryhopestospeedresearch.html

    (9)Pressrelease:http://www.nanoporetech.com/news/pressreleases/view/39

    (10)http://www.nature.com/news/norwaytobringcancergeneteststotheclinic1.9949

    (11)HutchinsonIII,C.A.(2007)DNAsequencing:BenchtoBedsideandBeyond.NucleicAcidsResearch,35:18(62276237)doi.10.1093/nar/gkm688

    (12)http://www.nobelprize.org/nobel_prizes/chemistry/laureates/1980/

    http://obrreview.com/2012/role-of-non-coding-mirna-in-infectious-diseases

  • 3/11/2015 WhatssospecialaboutNextGenerationsequencing?OxbridgeBiotechRoundtable

    http://www.oxbridgebiotech.com/review/researchandpolicy/whatssospecialaboutnextgenerationsequencing/ 7/8

    (13)http://www.wellcome.ac.uk/Educationresources/Teachingandeducation/Animations/DNA/WTX056046.htm

    (14)http://wellcome.ac.uk/Educationresources/Teachingandeducation/Animations/DNA/WTX056051.htm

    (15)Youtubevideo:http://www.youtube.com/watch?v=Sx6FbYoFGmM

    (16)http://www.nanoporetech.com/technology/introductiontonanoporesensing/introductiontonanoporesensing

    (17)http://www.nature.com/news/nanoporegenomesequencermakesitsdebut1.10051

    (18)www.nature.com/news/dnadonorrightsaffirmed1.10275

    (19)http://news.sciencemag.org/scienceinsider/2012/03/biobanksaskedtohelpdeliver.html?ref=hp

    (20)Robertson,(2003)The$1000Genome:EthicalandLegalIssuesinWholeGenomeSequencingofIndividuals.TheAmericanJournalofBioethics,InFocus.

    (21)RebeccaSkloot(2010),TheImmortalLifeofHenriettaLacks,CrownBooks,February2,20101stEdition,ISBN9781400052172

    (22)Roche(2010),TheProperty/PrivacyConundrumoverHumanTissue,HECForum22:197209DOI10.1007/s1073001091372

    (23)Coryell(2011)PatentLawasanIncentivetoInnovatenotDonate:TheRoleoftheUSPatentSysteminregulatingOwnershipofHumanTissue,PhDThesis?

    (24)http://www.sciencemag.org/content/305/5688/1226.2.full.pdf

    (25)http://content.healthaffairs.org/content/22/5/166.full

    (26)http://www.science20.com/news_articles/nextgeneration_sequencing_leads_personalized_medicine_win_teenager80079

    (27)http://www.nature.com/news/2011/110615/full/news.2011.368.html

    (28)http://www.pharmamanufacturing.com/articles/2008/007.html

    Thispostwaswrittenby:

    SarahEtheridgeViewauthorbio

    ThisworkislicensedunderaCreativeCommonsAttribution4.0InternationalLicense.

    OBRConsulting

    InnovativeBusinessConsulting

    OBRConsultingisauniqueopportunityforresearchersandstudentstogainexperienceinconsultancyprojectsattheintersectionofscience,businessandentrepreneurship.

    Learnmore

    ContributetotheOBRcommunitysubscribetodayforfree

    http://creativecommons.org/licenses/by/4.0/http://www.oxbridgebiotech.com/obrconsultinghttp://oxbridgebiotech.com/obrconsultinghttp://creativecommons.org/licenses/by/4.0/

  • 3/11/2015 WhatssospecialaboutNextGenerationsequencing?OxbridgeBiotechRoundtable

    http://www.oxbridgebiotech.com/review/researchandpolicy/whatssospecialaboutnextgenerationsequencing/ 8/8

    JoinOBR

    Sitemap

    HomeReviewOBRConsultingOneStartEventsAbout

    TwitterFacebookLinkedInJoinOBR

    @OxbridgeBiotech

    3daysago@AndyBiotech@octamerunivreservesrightto100%ofequityreceivedinIPlicensetostartup.butthatequityreceived